Vaccine Market to Witness Considerable Growth in 2020 and 2021 due to the growing demand of COVID-19 vaccine

Evolve business intelligence, today has published a new market research report on “The global Vaccine market was valued at $ 34.83 billion in 2019 and is anticipated to grow at a CAGR of 9.0% from 2020 to 2027.

For more information on the report: https://evolvebi.com/product/vaccine-market-analysis-and-forecast-2020-2027-with-covid-impact-analysis/

The COVID-19 pandemic has led to disruption in the supply chain leading to lower demand or supply shortages in the Vaccine market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is expected to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company.

In terms of COVID 19 impact, the Vaccine market report also includes the following data points:
• COVID19 Impact on Vaccine market size
• End-User/Industry/Application Trend, and Preferences
• Government Policies/Regulatory Framework
• Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
• Opportunity in the Vaccine market

Analyst View
According to Nisha, Principal Analyst, Evolve Business Intelligence, “The Covid19 outbreak has negatively impacted the growth of various markets including aviation, automobile, and others. However, the vaccine market is the most opportunistic market during this pandemic situation. The solution to this crisis is to develop a vaccine that can stop this severe outbreak. The various pharmaceutical companies, research, and development associations and institutions are working on developing a vaccine to cure the disease.”

Competitive Scenario
Some of the major Vaccine players holding high market share include GSK, Merck & Co, Sanofi, and Pfizer. These players New product development and partnership & collaboration as a key strategy to gain significant market share to compete with market leaders.

Segmental Analysis
The global Vaccine market is segmented based on Indication, Type, and Technology. On the basis of Indication, the Pneumococcal Disease segment accounts for the highest share in 2019 and it is expected to grow considerably during the forecast period. On the basis of Type, the multivalent segment accounts for the largest market share in 2019. Based on technology, Conjugate Vaccines accounts for the largest market share and is expected to grow at a CAGR of 9.7% during the forecast period.

Report Coverage
The study also contains a comprehensive value chain, as well as details on the key factors affecting the market growth (drivers, constraints, and opportunities). Furthermore, the report includes 20 key players in the Vaccine market ecosystem that have been strategically profiled, along with the market ranking/share for major players. Under the company profile section, the company’s core competencies have been comprehensively analyzed, along with detailing the competitive landscape for the market players, and the strategies such as partnerships and collaboration, acquisitions, product launches and developments, contracts, and business expansion adopted by them to grow in the market.

The key players profiled in the report are:
• BAVARIAN NORDIC
• SINOVAC BIOTECH LTD.
• PANACEA BIOTEC
• DYNAVAX TECHNOLOGIES CORPORATION
• BHARAT BIOTECH
• ASTELLAS PHARMA INC
• MERCK & CO., INC.
• SANOFI PASTEUR
• ASTRAZENECA
• SERUM INSTITUTE OF INDIA PVT. LTD.
• VALNEVA
• PFIZER
• MITSUBISHI TANABE PHARMA
• EMERGENT BIOSOLUTIONS INC.
• SEQIRUS (CSL LTD)
• GLAXOSMITHKLINE PLC
• HUALAN BIOLOGICAL ENGINEERING INC
• GRIFOLS
• BIOLOGICAL E. LIMITED
• MEDICAGO

To request a free sample report, click on the “Request Sample PDF” button on https://evolvebi.com/product/vaccine-market-analysis-and-forecast-2020-2027-with-covid-impact-analysis/

Research Methodology
This research study makes substantial use of secondary sources, archives, and databases (such as annual reports, news releases, magazines, Trademap, company websites, and other paid databases) to classify and gather information valuable for this analysis. The entire process involves a review of top industry participants' financial records. Following the determination of the overall market size, the total market was divided into several segments and sub-segments, and this information was then verified through key industry specialists such as CEOs, directors, VPs, and marketing executives.

Report Objectives
• To define, describe, and forecast the Vaccine market, in terms of value, segmented on the basis of indication, type, technology, and geography
• To forecast the market size across 4 key regions—Asia Pacific (APAC), North America, Europe, and Rest of the World (RoW)
• To provide detailed information regarding drivers, restraints, and opportunities, in the Vaccine market
• To provide an overview of the value chain analysis pertaining to the Vaccine industry
• To strategically analyze each segment and subsegment with respect to individual overall growth trends and their contribution to the overall Vaccine market
• To analyze opportunities in the market by identifying high-growth segments of the Vaccine market
• To profile key players in the Vaccine market and comprehensively analyze their core competencies
• To analyze competitive developments such as partnerships, product launches and developments, contracts, and mergers and acquisitions carried out in the global Vaccine market

Evolve Business Intelligence
C-218, 2nd floor, M-Cube
NH 48, Balitha, Vapi
Gujarat 396191
India

Email: sales@evolvebi.com
Website: https://evolvebi.com/

Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

This release was published on openPR.